Cargando…

MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis

Breast cancer (BCa) is the leading cause of death by cancer in women worldwide. This disease is mainly stratified in four subtypes according to the presence of specific receptors, which is important for BCa aggressiveness, progression and prognosis. MicroRNAs (miRNAs) are small non-coding RNAs that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farré, Paula Lucía, Duca, Rocío Belén, Massillo, Cintia, Dalton, Guillermo Nicolás, Graña, Karen Daniela, Gardner, Kevin, Lacunza, Ezequiel, De Siervi, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539154/ https://www.ncbi.nlm.nih.gov/pubmed/34681793 http://dx.doi.org/10.3390/ijms222011135

Ejemplares similares

Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients
por: Duca, Rocío Belén, et al.
Publicado: (2022)

Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development
por: Massillo, Cintia, et al.
Publicado: (2020)

CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis
por: Farré, Paula L., et al.
Publicado: (2018)

CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice
por: Dalton, Guillermo Nicolás, et al.
Publicado: (2019)

CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs
por: De Luca, Paola, et al.
Publicado: (2016)

miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3
por: Gu, Hao, et al.
Publicado: (2019)

Observatory wins GBP 10.6m contract
por: Dalton, A W
Publicado: (2003)

Methylation‐associated miR‐193b silencing activates master drivers of aggressive prostate cancer
por: Mazzu, Ying Z., et al.
Publicado: (2019)

Clinical Value of Serum miR-106a in the Diagnosis and Prognosis of Human Papillomavirus-Positive Cervical Cancer
por: Rao, Xiaoyan, et al.
Publicado: (2023)

The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25
por: Khuu, Cuong, et al.
Publicado: (2016)

The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors
por: Gruszka, Renata, et al.
Publicado: (2018)

Relationship between Serum miR-106 and MYL4 Levels and the Prevalence, Risk Stratification, and Prognosis of Atrial Fibrillation
por: Liu, Yanfeng, et al.
Publicado: (2022)

miR-106b suppresses pathological retinal angiogenesis
por: Ménard, Catherine, et al.
Publicado: (2020)

miR-106b as an emerging therapeutic target in cancer
por: Sagar, Surendra Kumar
Publicado: (2021)

Neuroinflammation-associated miR-106a-5p serves as a biomarker for the diagnosis and prognosis of acute cerebral infarction
por: Du, Wei, et al.
Publicado: (2023)

miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling
por: Lu, Jun, et al.
Publicado: (2017)

Retroviral activation of the mir-106a microRNA cistron in T lymphoma
por: Lum, Amy M, et al.
Publicado: (2007)

Diagnostic and prognostic value of miR-106a in colorectal cancer
por: Hao, Haibin, et al.
Publicado: (2016)

Mir106b-25 and Mir17-92 Are Crucially Involved in the Development of Experimental Neuroinflammation
por: Finardi, Annamaria, et al.
Publicado: (2020)

Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma
por: Li, Bin-Kui, et al.
Publicado: (2014)

TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma
por: Duan, Jicheng, et al.
Publicado: (2021)

miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging
por: Hackl, Matthias, et al.
Publicado: (2010)

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
por: Huh, J H, et al.
Publicado: (2013)

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
por: Nakka, Manjula, et al.
Publicado: (2017)

miR-106a deficiency attenuates inflammation in murine IBD models.
por: Sanctuary, Megan R., et al.
Publicado: (2018)

Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol
por: Chen, Kuan-Hui Ethan, et al.
Publicado: (2017)

Overview of miR-106a Regulatory Roles: from Cancer to Aging
por: Daneshpour, Maryam, et al.
Publicado: (2023)

Detargeting Lentiviral-Mediated CFTR Expression in Airway Basal Cells Using miR-106b
por: Choi, Soon H., et al.
Publicado: (2020)

Addendum to proposal P 106: consideration on the time scale for P106
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1980)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

FreeSWITCH 106
por: Minessale, Anthony, et al.
Publicado: (2010)

S106. Submission Withdrawn
Publicado: (2018)

Clinical factors affecting the determination of radiotherapy-induced skin toxicity in breast cancer
por: Córdoba, Elisa Eugenia, et al.
Publicado: (2021)

Growth-Promoting Role of the miR-106a∼363 Cluster in Ewing Sarcoma
por: Dylla, Layne, et al.
Publicado: (2013)

Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
por: Shi, Bao-Min, et al.
Publicado: (2017)

Master Data Management in Practice: Achieving True Customer MDM
por: Cervo, Dalton
Publicado: (2011)

GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer
por: Guo, Yanxia, et al.
Publicado: (2019)

The Human Factor in Maritime Transport: Personality and Aggression Levels of Master Mariners and Navigation Students
por: Makarowski, Ryszard, et al.
Publicado: (2020)

Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

Transcriptional regulation of BRCA1 expression by a metabolic switch
por: Di, Li-Jun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sk1p3l3rtan10o6a817ldoqvag